Study guide
4.9 Evidence-Based Ergogenic Aids & Prohibited Substances
NSCA Tactical Strength and Conditioning Facilitator TSAC-F
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: TSAC-F Exam Orientation & Blueprint
About the TSAC-F Exam: Format, Scoring, Eligibility & Policies The TSAC-F Detailed Content Outline: Domains, Weights & Cognitive Levels
2 Chapter 2: Anatomy, Biomechanics & Neuromuscular Physiology
2.1 Muscular Anatomy, Fiber Types & Motor Unit Recruitment 2.2 Skeletal & Connective Tissue Adaptations to Tactical Loading 2.3 Biomechanical Principles, Levers & Movement Mechanics 2.4 Neuromuscular Mechanisms: Spindles, GTOs & Stretch-Shortening Cycle
3 Chapter 3: Bioenergetics, Endocrine & Environmental Physiology
3.1 Bioenergetics: Phosphagen, Glycolytic & Oxidative Energy Systems 3.2 Cardiopulmonary Responses & Aerobic/Anaerobic Adaptations 3.3 Endocrine Responses to High-Intensity Exercise & Chronic Stress 3.4 Environmental Stressors: Heat, Cold, Altitude & Protective Gear
4 Chapter 4: Tactical Nutrition, Hydration & Supplementation
4.1 Tactical Energy Requirements & Carbohydrate Fueling 4.2 Protein, Dietary Fat & Building the Macronutrient Plan 4.3 Food-Group Guidance, Nutrient Density & Diet-Related Chronic Disease Risk 4.4 Thermoregulation, Sweat Rate Calculation & Dehydration Thresholds 4.5 Fluid Replacement Protocols, Hydration Assessment & Hyponatremia 4.6 Combat Rations: MREs, Field Stripping & First Strike Rations 4.7 Shift-Work Chrononutrition & Austere-Environment Feeding 4.8 Supplement Scope of Practice, DSHEA Regulation & Third-Party Testing 4.9 Evidence-Based Ergogenic Aids & Prohibited Substances 4.10 Disordered Eating, RED-S & Registered Dietitian Referral
5 Chapter 5: Fundamental Movement, Warm-Up & Resistance Technique
5.1 Dynamic Warm-up, RAMP Protocol & Mobility/Flexibility Methods 5.2 Core Resistance Exercises: Free Weights, Spotting & Valsalva Mechanics 5.3 Machine-Based, Cable & Bodyweight Resistance Techniques 5.4 Movement Screening & Technique Correction in Tactical Training
6 Chapter 6: Explosive Power, Agility & Tactical Implement Training
6.1 Plyometric Training Mechanics, Progressions & Landing Safety 6.2 Speed Mechanics, Acceleration & Change of Direction vs. Agility 6.3 Alternative Tactical Implements: Tires, Sandbags, Sleds & Farmer Carries 6.4 Tactical Load Carriage (Rucking) Mechanics & Injury Reduction
7 Chapter 7: Testing Administration, Health Screening & Body Composition
7.1 Pre-Participation Screening Purpose, PAR-Q+ & Medical History 7.2 Risk Stratification, Blood Pressure Screening & Informed Consent 7.3 Testing Selection, Validity, Reliability & Test Battery Sequencing 7.4 Body Mass, BMI Limitations & Body Composition Modalities 7.5 DoD Circumference Taping & Operational Implications of Adiposity
8 Chapter 8: Tactical Physical Fitness & Performance Testing
8.1 Muscular Strength Testing: 1RM Protocol & Submaximal Prediction 8.2 Isometric Strength, Explosive Power & Muscular Endurance Testing 8.3 Anaerobic Capacity & Alactic Power Field Tests 8.4 Aerobic Field Tests, Yo-Yo Protocols & Environmental Test Safety 8.5 Military & Law Enforcement Physical Employment Standards 8.6 Firefighter CPAT, Daily Readiness Tracking & Testing Accommodations
9 Chapter 9: Program Design Principles & Periodization Models
9.1 Foundational Training Principles: Overload, Specificity & Reversibility 9.2 Stress-Response Models: GAS & the Fitness-Fatigue Paradigm 9.3 Acute Program Variables: Sets, Reps, Intensity, Rest & Exercise Order 9.4 The Periodization Hierarchy & Tactical Periodization Models 9.5 Residual Training Effects, Deloads & a 4-Week Tactical DUP Template 9.6 Circumstantial & Lifestyle Factors in the Tactical Needs Analysis
10 Chapter 10: Branch-Specific Tactical Program Design
10.1 Military Occupational Demands & the 4-Phase Deployment Cycle 10.2 Ruck March Progression & Army Fitness Test Conditioning 10.3 Law Enforcement Physical Preparation & Duty-Gear Conditioning 10.4 Structural & Wildland Firefighter Conditioning & Thermal Prep
11 Chapter 11: Concurrent Training, Load Management & Readiness
11.1 Concurrent Training & Minimizing the Interference Effect 11.2 Workload Monitoring: Acute-to-Chronic Workload Ratio (ACWR) 11.3 The Training Stress Continuum: Overreaching vs. Overtraining Syndrome 11.4 Overtraining Biomarkers, Detraining Dynamics & Retraining Protocols 11.5 Passive vs. Active Recovery & Individualized Recovery Modalities
12 Chapter 12: Tactical Wellness, Injury Prevention & Operational Stress
12.1 Operational Stress, Autonomic Regulation & Mental Resilience Skills 12.2 Sleep Physiology, Shift Work Adaptation & Fatigue Countermeasures 12.3 Common Tactical Musculoskeletal Injuries & Return-to-Duty Continuum 12.4 Occupational Health Risks: Cardiovascular Health & Chronic Disease Mitigation 12.5 Advantages of Different Physical Activity Modes & Risks of Inappropriate Training
13 Chapter 13: Facility Administration, Policies & Professional Ethics
13.1 Tactical Training Facility Design, Equipment Layout & Traffic Flow 13.2 Facility Policies, Maintenance Schedules & Sanitation Standards 13.3 Emergency Action Plans (EAP), Safety Protocols & Risk Management 13.4 Training Records, Documentation & Program Data Management 13.5 Large-Group Training Logistics, Supervision & Limited Equipment 13.6 Program Effectiveness Metrics, KPIs & Demonstrating Value 13.7 The Role of the Interdisciplinary Human Performance Team 13.8 TSAC-F Professional Scope of Practice, Legal Liabilities & Ethics
4.9 Evidence-Based Ergogenic Aids & Prohibited Substances
Key Takeaways Explain This Topic AI
Creatine monohydrate is the best-supported ergogenic aid for tactical populations, dosed at 3-5 g/day chronically or 20 g/day split across four doses for 5-7 days as a loading protocol.
Caffeine improves vigilance, reaction time, and time to exhaustion at roughly 3-6 mg/kg taken 30-60 minutes before the demand, with diminishing returns and rising side effects above that range.
Prohibited substances including Anabolic Androgenic Steroids (AAS), SARMs, DMAA, and ephedra are banned by the Department of Defense and most agencies, and are frequently present in products that do not declare them.
Protein powders and buffers such as beta-alanine and sodium bicarbonate are legitimate but secondary: they add value only after energy availability, total protein, and sleep are already handled.
Last updated: September 2026
4.9 Evidence-Based Ergogenic Aids & Prohibited Substances
Quick Summary: This section grades the supplements a tactical athlete will actually ask about, from creatine and caffeine down to protein powders and buffers, and then catalogues the prohibited compounds - anabolic steroids, SARMs, stimulant analogues - whose use ends careers and injures operators.
Evidence-Based Tier 1 Ergogenic Aids
The TSAC-F must direct athletes toward supplements categorized as Tier 1 (Substantial Scientific Evidence Supporting Efficacy and Safety) . In tactical sports nutrition, three primary supplements form this foundation:
1. Creatine Monohydrate
Mechanism of Action: Ingested creatine is phosphorylated into intramuscular phosphocreatine (PCr) , stored primarily in fast-twitch (Type II) skeletal muscle fibers. PCr acts as a rapid biochemical buffer that donates a high-energy phosphate group to ADP, regenerating ATP via the reversible creatine kinase reaction: ADP + PCr + H + ↔ ATP + Creatine \text{ADP} + \text{PCr} + \text{H}^+ \leftrightarrow \text{ATP} + \text{Creatine} ADP + PCr + H + ↔ ATP + Creatine . This accelerates anaerobic ATP resynthesis during repeated maximal-intensity efforts lasting under 10-15 seconds.
Evidence-Based Dosing:
Loading Protocol: 20 g/day 20 \text{ g/day} 20 g/day (administered as four 5 g 5 \text{ g} 5 g doses spaced throughout the day) for 5 to 7 days , followed by a maintenance dose of 3 to 5 g/day .
Chronic Low-Dose Protocol: 3 to 5 g/day 3 \text{ to } 5 \text{ g/day} 3 to 5 g/day continuously without a loading phase; achieves full muscle creatine saturation within 28 days with zero gastrointestinal discomfort.
Tactical Benefits: Significant enhancements in repeated sprint ability, explosive breaching power, 1RM strength, and lean mass accrual. Crucially for tactical personnel, emerging neurochemical research demonstrates that creatine crosses the blood-brain barrier, providing neuroprotection against concussive blast mild traumatic brain injury (mTBI) and attenuating cognitive decline during 24- to 36-hour sustained sleep deprivation.
Side Effects: Acute initial weight gain of 1 to 2 kg due to intracellular osmotic fluid retention (which is functional intracellular water, not adipose tissue or extracellular edema).
2. Caffeine (1,3,7-Trimethylxanthine)
Mechanism of Action: Rapidly absorbed hydrophobic alkaloid that crosses the blood-brain barrier. It acts primarily as a competitive adenosine A 1 A_1 A 1 and A 2 A A_{2A} A 2 A receptor antagonist in the central nervous system. By blocking adenosine, caffeine stimulates the downstream release of dopamine, noradrenaline, and acetylcholine, increasing motor unit recruitment firing frequencies and reducing the subjective Rating of Perceived Exertion (RPE) .
Evidence-Based Dosing:
Acute Performance Protocol: 3 to 6 mg/kg 3 \text{ to } 6 \text{ mg/kg} 3 to 6 mg/kg of body mass (approx. 240-480 mg for an 80 kg operator) consumed 45 to 60 minutes prior to operational tasks or physical fitness tests.
Sustained Operational Sustenance: Micro-doses of 100 to 200 mg 100 \text{ to } 200 \text{ mg} 100 to 200 mg every 2 to 3 hours during prolonged night watches or sustained multi-day field exercises (capping total intake at ≤ 400 mg/day \le 400 \text{ mg/day} ≤ 400 mg/day ).
Tactical Benefits: Marked improvements in marksmanship vigilance, rapid target discrimination, visual reaction time, upper-body muscular endurance, and prolonged aerobic work capacity.
Adverse Effects: Doses exceeding 6-9 mg/kg produce fine motor tremors (impairing trigger control), sinus tachycardia, acute anxiety/panic, gastrointestinal hypermotility, and severe disruption of deep restorative sleep.
3. Beta-Alanine
Mechanism of Action: Beta-alanine is a non-proteogenic amino acid that serves as the rate-limiting precursor in the intramuscular synthesis of carnosine ( β -alanyl-L-histidine \beta\text{-alanyl-L-histidine} β -alanyl-L-histidine ). Carnosine acts as an intramuscular physicochemical buffer that absorbs excess hydrogen ions ( H + \text{H}^+ H + ) generated during rapid anaerobic glycolysis, mitigating intracellular metabolic acidosis (preventing muscle pH from falling from 7.0 toward 6.5).
Evidence-Based Dosing: 3.2 to 6.4 g/day , ingested in divided doses of 1.6 g every 3 to 4 hours (or using sustained-release tablets) for a minimum of 4 to 8 weeks to elevate muscle carnosine stores by 40% to 80%.
Tactical Benefits: Improves high-intensity physical performance specifically in the 1- to 4-minute operational window —such as climbing multiple flights of stairs under full structural turnout gear, wrestling a combative suspect, dragging a casualty across open terrain, or executing high-speed room-clearing drills.
Side Effects: Acute paresthesia (a harmless, transient tingling or prickling sensation on the skin of the face, neck, and hands) occurring approximately 20-30 minutes post-ingestion. Paresthesia is caused by beta-alanine binding to MrgprD G-protein coupled receptors on sensory neurons and is easily prevented by dividing doses into ≤ 1.6 g \le 1.6 \text{ g} ≤ 1.6 g portions.
Summary of Evidence-Based Dietary Supplements for Tactical Personnel
Ergogenic Aid Evidence Tier Primary Biochemical Mechanism Validated Dosing Protocol Key Tactical Application Potential Side Effects & Considerations
Creatine Monohydrate Tier 1 (Strongest Evidence) Phosphocreatine (PCr) resynthesis; rapid substrate for ATP-CP system 20 g/day (4 x 5 g) for 5–7 days, then 3–5 g/day maintenance (or 3–5 g/day chronic) Short-duration explosive power, sprinting, 1RM strength, blast mTBI neuroprotection Acute 1–2 kg fluid retention (intracellular water); well tolerated
Caffeine (Anhydrous) Tier 1 (Strongest Evidence) Adenosine A1 and A2A receptor antagonism; CNS catecholamine release 3–6 mg/kg 45–60 min prior to activity; micro-doses (100–200 mg) during sustained ops Sustained cognitive vigilance, marksmanship, reaction time, aerobic endurance Tremors, tachycardia, anxiety at >6 mg/kg; impairs deep N3 sleep if taken <6 hr before bed
Beta-Alanine Tier 1 (Strongest Evidence) Rate-limiting precursor to carnosine; buffers intramuscular H+ acidosis 3.2–6.4 g/day in divided doses (≤1.6 g each) for 4–8 weeks High-intensity work lasting 1–4 minutes (breaching, casualty drags, stair climbs) Transient paresthesia (harmless skin tingling); mitigated by divided doses
Whey Protein Isolate Tier 1 (Strongest Evidence) Rapidly digested essential amino acids; high leucine (~10–12%) triggers mTORC1 20–40 g post-exercise or between austere meals (delivering 2.5–3.0 g leucine) Muscle protein synthesis, lean mass preservation during hypocaloric duty Minimal; safe for individuals without cow's milk protein allergy
Micellar Casein Tier 1 (Strongest Evidence) Slow-digesting intact protein; sustained plasma amino acid elevation for 6–8 hours 30–40 g ingested 30 minutes prior to nocturnal sleep Overnight muscle protein synthesis, tissue remodeling during recovery windows Gastric fullness; avoid immediately pre-shift due to slow transit time
Sodium Bicarbonate Tier 2 (Contextual / Emerging) Extracellular buffer; increases trans-sarcolemmal H+ efflux 0.2–0.3 g/kg consumed 60–90 minutes prior to intense exertion Anaerobic capacity during 1–5 minute high-intensity tactical tasks High risk of gastrointestinal distress (severe cramping, osmotic diarrhea)
Secondary Supplements: Proteins & Buffers
Whey Protein Isolate & Hydrosylate: Rapidly digested, high-biological-value protein source providing 10-12% leucine by weight. Ideal for acute post-training recovery when whole foods are logistically impractical in the field.
Micellar Casein: Slow-digesting, coagulating milk protein that provides a sustained 6- to 8-hour plateau of circulating amino acids. Highly effective when consumed (30-40 g) prior to overnight sleep to elevate nocturnal muscle protein synthesis.
Sodium Bicarbonate (Extracellular Buffer): Ingesting 0.2 to 0.3 g/kg 0.2 \text{ to } 0.3 \text{ g/kg} 0.2 to 0.3 g/kg of sodium bicarbonate 60 to 90 minutes prior to high-intensity exertion elevates blood bicarbonate concentration, increasing the trans-sarcolemmal efflux of H + \text{H}^+ H + from active muscle fibers. While effective for 1- to 5-minute sustained anaerobic bouts, its high incidence of severe gastrointestinal distress (explosive diarrhea, nausea, vomiting) makes it a high-risk strategy in tactical settings.
Prohibited Substances & Physiological Toxicities
Tactical environments occasionally foster an underground culture of illicit performance-enhancing drug (PED) use. Operators seeking rapid physical size or recovery under grueling operational demands may turn to illegal compounds. The TSAC-F must clearly articulate the profound medical, legal, and operational hazards of these prohibited substances.
1. Anabolic-Androgenic Steroids (AAS)
Synthetic derivatives of the endogenous male sex hormone testosterone (e.g., nandrolone, stanozolol, trenbolone, boldenone).
Cardiovascular Remodeling: Induction of irreversible concentric left ventricular hypertrophy (LVH), myocardial fibrosis, decreased diastolic compliance, early-onset coronary atherosclerosis, severe dyslipidemia (drastic suppression of HDL to < 15 mg/dL <15 \text{ mg/dL} < 15 mg/dL , surge in atherogenic LDL), endothelial dysfunction, and sudden cardiac death.
Endocrine Shutdown: Profound suppression of the Hypothalamic-Pituitary-Gonadal (HPG) axis via negative feedback inhibition of GnRH, LH, and FSH. Results in severe testicular atrophy, azoospermia (infertility), erectile dysfunction, and gynecomastia (breast tissue proliferation via peripheral aromatization to estradiol).
Hepatic Pathology: 17 α \alpha α -alkylated oral steroids cause severe cholestatic jaundice, peliosis hepatis (blood-filled hepatic cysts), and hepatocellular carcinoma.
Neuropsychiatric Disturbances: Affective instability, manic aggression ("roid rage"), paranoia, and severe, refractory clinical depression accompanied by suicide risk upon compound cessation.
2. Selective Androgen Receptor Modulators (SARMs)
Non-steroidal compounds (e.g., ostarine/MK-2866, ligandrol/LGD-4033, testolone/RAD-140) marketed dishonestly on the internet as "side-effect-free legal steroid alternatives."
The Reality: SARMs are unapproved investigational new drugs that carry black-box FDA warnings. They induce marked endogenous testosterone suppression, hepatic enzyme elevation (hepatotoxicity), and adverse lipid shifts identical to anabolic steroids.
3. Prohibited Stimulants: DMAA, Ephedra & Prohormones
1,3-Dimethylamylamine (1,3-DMAA) & Analogs (DMBA, 1,4-DMAA): Potent synthetic vasoconstrictor and sympathomimetic amine. Mechanistically elevates systemic blood pressure and cardiac workload, directly implicated in fatal hemorrhagic strokes, cardiac arrests, and acute exertional heat stroke deaths during military training.
Ephedra & Ephedrine Alkaloids: Banned by the FDA in 2004 due to unreasonable risk of myocardial infarction, stroke, psychoses, and sudden death.
Prohibited Substances and Clinical Toxicities in Tactical Environments
Substance Class Common Examples Regulatory & Agency Status Primary Physiological Hazards Career & Legal Consequences
Anabolic-Androgenic Steroids (AAS) Nandrolone, Stanozolol, Trenbolone, Testosterone esters DEA Schedule III Controlled Substance; DoD Prohibited; WADA Banned Concentric left ventricular hypertrophy, myocardial fibrosis, severe dyslipidemia (HDL <15 mg/dL), testicular atrophy, hepatic adenomas, peliosis hepatis UCMJ Article 112a court-martial, dishonorable discharge, loss of pension, felony prosecution
Selective Androgen Receptor Modulators (SARMs) Ostarine (MK-2866), Ligandrol (LGD-4033), Testolone (RAD-140) Unapproved Investigational New Drugs; DoD Prohibited; FDA Warning Endogenous testosterone shutdown, liver enzyme elevations (hepatotoxicity), atherogenic lipid shifts, unknown long-term oncogenic potential Disciplinary discharge, employment termination, suspension from tactical teams
Synthetic Sympathomimetic Stimulants 1,3-Dimethylamylamine (1,3-DMAA), DMBA, Ephedra / Ephedrine FDA Banned from supplements; DoD Prohibited Ingredients List Severe vasoconstriction, systemic hypertension, acute hemorrhagic stroke, ventricular arrhythmia, exertional heat stroke deaths Banned from military bases, positive drug testing results, occupational disqualification
Growth Hormone Secretagogues & Peptides Ibutamoren (MK-677), GHRP-2, GHRP-6 Unapproved investigational agents; WADA and DoD Banned Hyperglycemia, peripheral insulin resistance, carpal tunnel syndrome, fluid extravasation, potential promotion of occult neoplasms Violation of agency substance policies; immediate administrative or medical separation
Legal & Career Consequences
In military and law enforcement jurisdictions, possession or use of anabolic steroids (DEA Schedule III Controlled Substances) or DoD-banned substances constitutes a direct violation of Article 112a of the Uniform Code of Military Justice (UCMJ) or departmental law enforcement standards. Penalties include court-martial, immediate dishonorable discharge or termination of employment, forfeiture of all veteran or law enforcement retirement pensions, and potential federal imprisonment.